Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction.

Abstract

Dysphagia associated with upper esophageal sphincter (UES) dysfunction remarkably affects the quality of life of patients. UES injection of botulinum toxin is an effective treatment for dysphagia. In comparison with skeletal muscles of the limb and trunk, the UES is a special therapeutic target of botulinum toxin injection, owing to its several anatomical, physiological, and pathophysiological features. This review focuses on (1) the anatomy and function of the UES and the pathophysiology of UES dysfunction in dysphagia and why the entire UES rather than the cricopharyngeal muscle before/during botulinum toxin injection should be examined and targeted; (2) the therapeutic mechanisms of botulinum toxin for UES dysfunction, including the choice of injection sites, dose, and volume; (3) the strengths and weaknesses of guiding techniques, including electromyography, ultrasound, computed tomography, and balloon catheter dilation for botulinum toxin injection of the UES.

• Authors: Pengxu Wei
• Journal: Toxins (Toxins (Basel)) Vol. 14 Issue 5 (04 30 2022) ISSN: 2072-6651 [Electronic] Switzerland
• PMID: 35622568 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)

Chemical References

• Botulinum Toxins, Type A

Topics

• Botulinum Toxins, Type A
• Deglutition Disorders (drug therapy)
• Esophageal Sphincter, Upper
• Humans
• Quality of Life
• Treatment Outcome